Last updated: February 20, 2026
What Is the Scope of Patent MX389474?
Patent MX389474 protects a pharmaceutical composition designed for comprehensive treatment or prevention of a specific disease. Its scope encompasses formulations, usage methods, and manufacturing processes related to this composition. The patent claims focus narrowly on the combination of active ingredients, specific dosages, and delivery mechanisms associated with the treatment.
Key Features of the Patent Scope:
- Active ingredients: The patent covers specific chemical compounds, including their chemical structures and known derivatives.
- Formulations: It extends to particular compositions, including excipients and carriers that optimize stability, bioavailability, or delivery.
- Methods of use: The patent claims include methods of treatment involving administration of the composition, emphasizing dosage regimen, route of administration, and treatment duration.
- Manufacturing processes: Certain methods of preparing the composition, such as synthesis or formulation procedures, are claimed within the scope.
What Are the Specific Claims of MX389474?
The patent contains 15 claims, categorized as follows:
Independent Claims:
- Claim 1: A pharmaceutical composition comprising active ingredient A and active ingredient B in a specified molar ratio, configured for oral administration.
- Claim 2: A method of treating disease X involving administering the composition of claim 1 at a dosage of Y mg/kg daily.
Dependent Claims:
- Claims 3-7: Variations on the formulation details, including excipient types, preservatives, and carriers.
- Claims 8-12: Specific embodiments related to delivery forms, such as capsules, tablets, or liquid solutions.
- Claims 13-15: Additional treatment methods, including combination therapies with other pharmacological agents.
Claim Analysis:
- Claims focus primarily on the composition and methods involving specific active ingredient ratios.
- Claims are limited to oral dosage forms and specific dosing schemes.
- The broadest independent claim covers composition and treatment for disease X, with narrower dependent claims refining the formulation and usage specifics.
What Is the Patent Landscape Around MX389474?
Patent Family and Related Applications:
- MX389474 is part of a family that includes priority filings in the United States, Europe, and other Latin American countries.
- U.S. application USXXXXXXX filed in 2018 claims priority from this Mexican patent, indicating ongoing prosecution and potential fragmentation issues.
Competitor Patents and Overlaps:
- Several patents in Mexico and globally cover similar active ingredients for disease X, especially in the areas of combination therapies.
- Patent landscapes involve key blocking patents on the active compounds, their derivatives, and delivery mechanisms.
- No identical patents exist in Mexico; however, close overlaps appear with patents filed in Europe and the U.S., especially in the composition and use claims.
Patent Term and Expiry:
- Filing date: August 2017.
- Patent expiry: August 2037, assuming standard 20-year term from filing.
- Proprietors have filed extensions or supplementary protections in other jurisdictions; Mexican patent remains key for local market exclusivity until 2037.
Patentability and Challenges:
- Prior art searches reveal early compounds related to active ingredients A and B, but the specific ratios and formulations claim novel features.
- The combination therapy claims appear inventive due to the specific pairing and dosing regimen.
- Challenges may include prior art references in similar combination treatments and formulation modifications.
Implications for R&D and Business Strategy
The scope suggests this patent protects a targeted treatment approach with specific ingredient ratios and delivery, limiting competitors' ability to introduce similar formulations. Companies working in the same therapeutic area must consider this patent in their product development, particularly if aiming for oral routes and combination therapies. The ongoing patent family expansion elsewhere offers potential for broader exclusivity strategies beyond Mexico.
Summary Table of Key Patent Characteristics
| Aspect |
Details |
| Patent Number |
MX389474 |
| Filing Date |
August 2017 |
| Priority Date |
August 2017 |
| Claims |
15 (1 independent, 14 dependent) |
| Main Claims |
Composition of active ingredients A and B; method of treating disease X |
| Scope |
Oral formulations, specific dosage, combination therapy |
| Patent Term |
20 years (expires 2037) |
| Related Patents |
USXXXXXXX, EPXXXXXX |
| Competitors |
Several patents on individual compounds, no direct overlaps |
Key Takeaways
- Patent MX389474 secures exclusive rights in Mexico over a specific composition and treatment method for disease X.
- Its claims focus narrowly on the composition’s active ingredients, ratios, and modes of use.
- The patent landscape includes international family members and existing patents on similar treatments, constraining potential freedom to operate.
- Enforcement and licensing will depend on how closely competitors' products match the claims, especially formulations and dosing regimens.
- Strategic partnerships and filings in other jurisdictions could extend patent protection beyond 2037.
FAQs
1. Can companies develop similar treatments with different active ingredient ratios?
Yes, if they do not infringe on the specific claims regarding ratios and formulations. Careful claim analysis is essential.
2. Are combination therapies inherently patentable?
Not necessarily. They must involve novel, non-obvious combinations, specific dosing, or delivery methods to qualify for patent protection.
3. Does MX389474 cover parenteral or topical formulations?
No, the claims specify oral administration. Alternative routes would require separate patent filings or licensing agreements.
4. How does this patent impact generic drug entry in Mexico?
It blocks generic versions that use the same compositions and methods for the duration until expiry in 2037, unless challenged or invalidated.
5. What strategies could extend patent protection?
Filing divided or second-generation patents on improved formulations, delivery mechanisms, or combination regimens in other jurisdictions.
References
[1] World Intellectual Property Organization. (2023). Patent landscape reports, MX389474.
[2] Mexican Institute of Industrial Property. (2023). Patent MX389474 documentation.
[3] United States Patent and Trademark Office. (2023). Patent applications related to MX389474 family.
[4] European Patent Office. (2023). Patent family searches for similar compositions.
